BioBridgeXAll companies

Kytopen Corp.

Biotechnology company · Cambridge, Massachusetts, United States

Kytopen Corp. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.9 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $7.1 million sold in a notice filed in 2025.

kytopen.comProfile compiled from public records. Is this your company? Request a correction or update

Kytopen at a glance

Typebiotechnology company
HeadquartersCambridge, Massachusetts, United States
Earliest incorporation on record2017
Employees (self-reported, 2024)30
SEC CIK1777277

What does Kytopen do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.9 million in total (2021 to 2024). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $7.1 million sold (2025).

Frequently asked questions about Kytopen

Where is Kytopen headquartered?

Kytopen Corp. is headquartered in Cambridge, Massachusetts, United States.

What does Kytopen do?

Kytopen Corp. is a biotechnology company.

When was Kytopen founded?

The earliest incorporation on record for Kytopen Corp. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences